In the last 12 months, insiders at Galera Therapeutics, Inc. ($GRTX) filed 61 transactions with the SEC: 32 open-market purchases totaling $1,469,250 and 8 sales totaling $818,080. Net insider sentiment: net buying.
Galera Therapeutics, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Altamont Pharmaceutical Holdings, LLC (TenPercentOwner) — 6 transactions totaling $811,848
- Schneid Yair (TenPercentOwner) — 28 transactions totaling $756,841
- CHANG NANCY T (Not found) — 3 transactions totaling $499,979
- Sorensen Mel (President and CEO) — 5 transactions totaling $174,352
- Bachleda Mark (Chief Commercial Officer) — 2 transactions totaling $24,717
View all SEC Filings for Galera Therapeutics, Inc. (GRTX).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 20, 2025 | Sorensen Mel | President and CEO | S | Common Stock | 70000 | $0.02 | 195,029.0000 | 98,503,430 | 26.41% | 0.07% |
| May 1, 2025 | Sorensen Mel | President and CEO | A | Stock Option (Right to Buy) | 6000000 | $0.00 | 6,000,000.0000 | 54,633,215 | 9999.99% | 10.98% |
| May 1, 2025 | Sussman Joel F. | Chief Accounting Officer | A | Stock Option (Right to Buy) | 2000000 | $0.00 | 2,000,000.0000 | 54,633,215 | 9999.99% | 3.66% |
| Feb. 24, 2025 | FRIEDMAN MICHAEL R. | Not found | A | Stock Option (Right to Buy) | 96000 | $0.00 | 96,000.0000 | 54,633,215 | 9999.99% | 0.18% |
| Feb. 24, 2025 | CHANG NANCY T | Not found | A | Stock Option (Right to Buy) | 96000 | $0.00 | 96,000.0000 | 54,633,215 | 9999.99% | 0.18% |
| Feb. 24, 2025 | Alleva Lawrence M | Not found | A | Stock Option (Right to Buy) | 48000 | $0.00 | 48,000.0000 | 54,633,215 | 9999.99% | 0.09% |
| Feb. 24, 2025 | LOKAY KEVIN G | Not found | A | Stock Option (Right to Buy) | 48000 | $0.00 | 48,000.0000 | 54,633,215 | 9999.99% | 0.09% |
| Dec. 30, 2024 | CHANG NANCY T | Not found | A | Series B Preferred Stock | 1842 | $0.00 | 1,841.9200 | 54,392,170 | 9999.99% | 0.00% |
| Dec. 30, 2024 | FRIEDMAN MICHAEL R. | Not found | A | Series B Preferred Stock | 8326 | $0.00 | 8,326.2690 | 54,392,170 | 9999.99% | 0.02% |
| Dec. 30, 2024 | CHANG NANCY T | Not found | P | Common Stock | 7644932 | $0.07 | 7,644,932.0000 | 54,392,170 | 9999.99% | 14.06% |
| Aug. 16, 2024 | Sorensen Mel | President and CEO | S | Common Stock | 67015 | $0.07 | 265,029.0000 | 44,549,285 | 20.18% | 0.15% |
| April 17, 2024 | Schneid Yair | TenPercentOwner | P | Common Stock | 243100 | $0.22 | 9,170,805.0000 | 44,549,285 | 2.72% | 0.55% |
| April 17, 2024 | Schneid Yair | TenPercentOwner | P | Common Stock | 551217 | $0.23 | 9,722,022.0000 | 44,549,285 | 6.01% | 1.24% |
| April 17, 2024 | Schneid Yair | TenPercentOwner | P | Common Stock | 453988 | $0.24 | 10,176,010.0000 | 44,549,285 | 4.67% | 1.02% |
| April 18, 2024 | Schneid Yair | TenPercentOwner | P | Common Stock | 17211 | $0.19 | 10,193,221.0000 | 44,549,285 | 0.17% | 0.04% |
| April 18, 2024 | Schneid Yair | TenPercentOwner | P | Common Stock | 100000 | $0.19 | 10,293,221.0000 | 44,549,285 | 0.98% | 0.22% |
| April 18, 2024 | Schneid Yair | TenPercentOwner | P | Common Stock | 100000 | $0.20 | 10,393,221.0000 | 44,549,285 | 0.97% | 0.22% |
| April 18, 2024 | Schneid Yair | TenPercentOwner | P | Common Stock | 247600 | $0.20 | 10,640,821.0000 | 44,549,285 | 2.38% | 0.56% |
| April 17, 2014 | Schneid Yair | TenPercentOwner | P | Common Stock | 318150 | $0.19 | 8,361,353.0000 | 0 | 3.96% | 0.00% |
| April 17, 2024 | Schneid Yair | TenPercentOwner | P | Common Stock | 100000 | $0.19 | 8,461,353.0000 | 44,549,285 | 1.20% | 0.22% |
| April 17, 2024 | Schneid Yair | TenPercentOwner | P | Common Stock | 68424 | $0.20 | 8,529,777.0000 | 44,549,285 | 0.81% | 0.15% |
| April 17, 2024 | Schneid Yair | TenPercentOwner | P | Common Stock | 241028 | $0.20 | 8,770,805.0000 | 44,549,285 | 2.83% | 0.54% |
| April 17, 2024 | Schneid Yair | TenPercentOwner | P | Common Stock | 56900 | $0.21 | 8,827,705.0000 | 44,549,285 | 0.65% | 0.13% |
| April 17, 2024 | Schneid Yair | TenPercentOwner | P | Common Stock | 50000 | $0.21 | 8,877,705.0000 | 44,549,285 | 0.57% | 0.11% |
| April 17, 2024 | Schneid Yair | TenPercentOwner | P | Common Stock | 50000 | $0.21 | 8,927,705.0000 | 44,549,285 | 0.56% | 0.11% |
| April 18, 2024 | Schneid Yair | TenPercentOwner | P | Common Stock | 4245 | $0.20 | 10,645,066.0000 | 44,549,285 | 0.04% | 0.01% |
| April 18, 2024 | Schneid Yair | TenPercentOwner | P | Common Stock | 4342 | $0.20 | 10,649,408.0000 | 44,549,285 | 0.04% | 0.01% |
| April 18, 2024 | Schneid Yair | TenPercentOwner | P | Common Stock | 74202 | $0.20 | 10,723,610.0000 | 44,549,285 | 0.70% | 0.17% |
| April 19, 2024 | Schneid Yair | TenPercentOwner | P | Common Stock | 100 | $0.19 | 10,723,710.0000 | 44,549,285 | 0.00% | 0.00% |
| April 19, 2024 | Schneid Yair | TenPercentOwner | P | Common Stock | 314 | $0.19 | 10,724,024.0000 | 44,549,285 | 0.00% | 0.00% |
| April 19, 2024 | Schneid Yair | TenPercentOwner | P | Common Stock | 215 | $0.19 | 10,724,239.0000 | 44,549,285 | 0.00% | 0.00% |
| April 19, 2024 | Schneid Yair | TenPercentOwner | P | Common Stock | 99371 | $0.19 | 10,823,610.0000 | 44,549,285 | 0.93% | 0.22% |
| March 22, 2024 | Altamont Pharmaceutical Holdings, LLC | TenPercentOwner | S | Common Stock | 20000 | $0.23 | 4,860,000.0000 | 44,549,285 | 0.41% | 0.04% |
| Jan. 11, 2024 | Altamont Pharmaceutical Holdings, LLC | TenPercentOwner | S | Common Stock | 400000 | $0.23 | 4,880,000.0000 | 44,549,285 | 7.58% | 0.90% |
| March 25, 2024 | Altamont Pharmaceutical Holdings, LLC | TenPercentOwner | S | Common Stock | 780000 | $0.22 | 4,080,000.0000 | 44,549,285 | 16.05% | 1.75% |
| March 26, 2024 | Altamont Pharmaceutical Holdings, LLC | TenPercentOwner | S | Common Stock | 2000000 | $0.20 | 2,080,000.0000 | 44,549,285 | 49.02% | 4.49% |
| March 27, 2024 | Altamont Pharmaceutical Holdings, LLC | TenPercentOwner | S | Common Stock | 306924 | $0.17 | 1,773,076.0000 | 44,549,285 | 14.76% | 0.69% |
| March 28, 2024 | Altamont Pharmaceutical Holdings, LLC | TenPercentOwner | S | Common Stock | 693076 | $0.15 | 1,080,000.0000 | 44,549,285 | 39.09% | 1.56% |
| Jan. 30, 2024 | Schneid Yair | TenPercentOwner | P | Common Stock | 335000 | $0.18 | 7,595,801.0000 | 44,549,285 | 4.61% | 0.75% |
| Feb. 6, 2024 | Schneid Yair | TenPercentOwner | P | Common Stock | 25000 | $0.20 | 7,718,203.0000 | 44,549,285 | 0.32% | 0.06% |
| Feb. 8, 2024 | Schneid Yair | TenPercentOwner | P | Common Stock | 150000 | $0.17 | 8,043,203.0000 | 44,549,285 | 1.90% | 0.34% |
| Feb. 7, 2024 | Schneid Yair | TenPercentOwner | P | Common Stock | 150000 | $0.17 | 7,893,203.0000 | 44,549,285 | 1.94% | 0.34% |
| Feb. 7, 2024 | Schneid Yair | TenPercentOwner | P | Common Stock | 25000 | $0.17 | 7,743,203.0000 | 44,549,285 | 0.32% | 0.06% |
| Feb. 5, 2024 | Schneid Yair | TenPercentOwner | P | Common Stock | 97402 | $0.18 | 7,693,203.0000 | 44,549,285 | 1.28% | 0.22% |
| Jan. 29, 2024 | Schneid Yair | TenPercentOwner | P | Common Stock | 150000 | $0.18 | 7,260,801.0000 | 44,549,285 | 2.11% | 0.34% |
| July 1, 2023 | Alleva Lawrence M | Not found | A | Stock Option (Right to Buy) | 22762 | $0.00 | 22,762.0000 | 0 | 9999.99% | 0.00% |
| July 1, 2023 | West Linda | Not found | A | Stock Option (Right to Buy) | 23382 | $0.00 | 23,382.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2023 | West Linda | Director | A | Stock Option (Right to Buy) | 48000 | $0.00 | 48,000.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2023 | LOKAY KEVIN G | Director | A | Stock Option (Right to Buy) | 48000 | $0.00 | 48,000.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2023 | Cunningham Emmett | Director | A | Stock Option (Right to Buy) | 48000 | $0.00 | 0.0000 | 0 | 0.00% | 0.00% |
| June 14, 2023 | Alleva Lawrence M | Director | A | Stock Option (Right to Buy) | 48000 | $0.00 | 48,000.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2023 | POWELL MICHAEL | Director | A | Stock Option (Right to Buy) | 64000 | $0.00 | 64,000.0000 | 0 | 9999.99% | 0.00% |
| March 16, 2023 | Bachleda Mark | Chief Commercial Officer | P | Common Stock | 11000 | $2.25 | 11,000.0000 | 0 | 9999.99% | 0.00% |
| March 10, 2023 | Sorensen Mel | President and CEO | P | Common Stock | 100000 | $1.68 | 332,044.0000 | 0 | 43.10% | 0.00% |
| March 13, 2023 | Degnan Chris | Chief Financial Officer | P | Common Stock | 10000 | $1.96 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 25, 2023 | Bachleda Mark | Chief Commercial Officer | A | Stock Option (Right to Buy) | 135000 | $0.00 | 135,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 25, 2023 | Kennedy Eugene P. | Chief Medical Officer | A | Stock Option (Right to Buy) | 55000 | $0.00 | 55,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 25, 2023 | Degnan Chris | Chief Financial Officer | A | Stock Option (Right to Buy) | 185000 | $0.00 | 185,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 25, 2023 | Sorensen Mel | President and CEO | A | Stock Option (Right to Buy) | 440000 | $0.00 | 440,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 25, 2023 | Beardsley Robert A | Chief Operating Officer | A | Stock Option (Right to Buy) | 135000 | $0.00 | 135,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 25, 2023 | Stacey Jennifer Evans | See Remarks | A | Stock Option (Right to Buy) | 135000 | $0.00 | 135,000.0000 | 0 | 9999.99% | 0.00% |